These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 14586253)

  • 21. Diagnosis and therapy of nonalcoholic steatohepatitis.
    Torres DM; Harrison SA
    Gastroenterology; 2008 May; 134(6):1682-98. PubMed ID: 18471547
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Obesity and non-alcoholic steatohepatitis].
    Méndez-Sánchez N; Chávez-Tapia NC; Uribe M
    Gac Med Mex; 2004; 140 Suppl 2():S67-72. PubMed ID: 15641474
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Treatment of non-alcoholic steatohepatitis].
    Fehér J; Hagymási K
    Orv Hetil; 2004 Mar; 145(12):631-4. PubMed ID: 15119118
    [No Abstract]   [Full Text] [Related]  

  • 24. Steatohepatitis and unsuspected micronodular cirrhosis in Dorfman-Chanarin syndrome with documented ABHD5 mutation.
    Srinivasan R; Hadzić N; Fischer J; Knisely AS
    J Pediatr; 2004 May; 144(5):662-5. PubMed ID: 15127008
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypertension and fatty liver: guilty by association?
    Brookes MJ; Cooper BT
    J Hum Hypertens; 2007 Apr; 21(4):264-70. PubMed ID: 17273155
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Approach to the diagnosis and treatment of nonalcoholic fatty liver disease.
    Ong JP; Younossi ZM
    Clin Liver Dis; 2005 Nov; 9(4):617-34, vi. PubMed ID: 16207567
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nonalcoholic fatty liver disease and diabetes mellitus.
    Adams LA
    Endocr Res; 2007; 32(3):59-69. PubMed ID: 18092195
    [No Abstract]   [Full Text] [Related]  

  • 28. Fatty liver-seat of insulin resistance.
    Shah SN; Joshi SR
    J Assoc Physicians India; 2009 Mar; 57():197-8. PubMed ID: 19588646
    [No Abstract]   [Full Text] [Related]  

  • 29. Nonalcoholic steatohepatitis in donors for living donor liver transplantation.
    Lo CM
    Transplantation; 2007 Feb; 83(3):265-6. PubMed ID: 17297398
    [No Abstract]   [Full Text] [Related]  

  • 30. Invasive and non-invasive investigations for non-alcoholic steatohepatitis (NASH): The other face of the coin of histology.
    Ahmed MH
    Med Hypotheses; 2006; 66(3):679-80. PubMed ID: 16289367
    [No Abstract]   [Full Text] [Related]  

  • 31. Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.
    Harrison SA; Neuschwander-Tetri BA
    Clin Liver Dis; 2004 Nov; 8(4):861-79, ix. PubMed ID: 15464659
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular mechanisms and therapeutic targets in steatosis and steatohepatitis.
    Anderson N; Borlak J
    Pharmacol Rev; 2008 Sep; 60(3):311-57. PubMed ID: 18922966
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The future is around the corner: Noninvasive diagnosis of progressive nonalcoholic steatohepatitis.
    Baranova A; Younossi ZM
    Hepatology; 2008 Feb; 47(2):373-5. PubMed ID: 18220279
    [No Abstract]   [Full Text] [Related]  

  • 34. Immunohistochemical analysis in steatohepatitis: does it have a role in diagnosis and management?
    Snover D
    Am J Clin Pathol; 2005 Apr; 123(4):491-3. PubMed ID: 15743741
    [No Abstract]   [Full Text] [Related]  

  • 35. Preface.
    Harrison SA
    Clin Liver Dis; 2009 Nov; 13(4):xiii-xiv. PubMed ID: 19818301
    [No Abstract]   [Full Text] [Related]  

  • 36. Association of non-alcoholic steatohepatitis without significant fibrosis with hepatocellular carcinoma.
    Bullock RE; Zaitoun AM; Aithal GP; Ryder SD; Beckingham IJ; Lobo DN
    J Hepatol; 2004 Oct; 41(4):685-6. PubMed ID: 15464253
    [No Abstract]   [Full Text] [Related]  

  • 37. Unexpected liver failure after right hemihepatectomy for colorectal liver metastasis due to chemotherapy-associated steato-hepatitis: time for routine preoperative liver biopsy?
    Sotiropoulos GC; Saner FH; Molmenti EP; Radtke A; Timm S; Baba HA; Paul A; Lang H
    Int J Colorectal Dis; 2009 Feb; 24(2):241. PubMed ID: 18762953
    [No Abstract]   [Full Text] [Related]  

  • 38. Editorial.
    Girard J; Halimi S
    Diabetes Metab; 2008 Dec; 34(6 Pt 2):633. PubMed ID: 19195622
    [No Abstract]   [Full Text] [Related]  

  • 39. Treating nonalcoholic fatty liver disease.
    Méndez-Sánchez N; Arrese M; Zamora-Valdés D; Uribe M
    Liver Int; 2007 Nov; 27(9):1157-65. PubMed ID: 17919226
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In search of an ideal biomarker for nonalcoholic fatty liver disease.
    Bambha K; Yee HF
    Am J Gastroenterol; 2008 Jun; 103(6):1380-2. PubMed ID: 18510615
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.